Introduction {#Sec1}
============

Lobar atrophy is well recognised in association with both benign and malignant biliary obstruction, the most common aetiologies being post-cholecystectomy stricture and cholangiocarcinoma respectively \[[@CR1]--[@CR3]\]. Benign strictures result in atrophy as a result of lobar/segmental biliary obstruction, whereas cholangiocarcinoma can result in atrophy because of biliary obstruction and/or portal vein branch compromise \[[@CR3]--[@CR5]\]. In either situation the contralateral lobe often hypertrophies \[[@CR3], [@CR6]\].

If cholangiocarcinoma arises in a right or left hepatic duct, the resulting obstruction, with or without portal vein branch compromise, may lead to asymptomatic atrophy of that lobe, with jaundice not occurring until the tumour extends centrally to involve the confluence of the right and left hepatic ducts \[[@CR3]--[@CR5]\].

It is important to recognise the presence of lobar and segmental liver atrophy and hypertrophy, as it influences the surgical and interventional management of biliary obstruction \[[@CR3], [@CR7]\].

This pictorial essay describes the radiological findings of lobar and segmental atrophy associated with hilar cholangiocarcinoma. The impact of hilar biliary anatomical variants, which are relatively common, is highlighted as these have not been described previously and can result in unusual findings.

Lobar atrophy {#Sec2}
=============

Reduction in volume and ductal crowding {#Sec3}
---------------------------------------

On cross-sectional imaging, lobar atrophy is usually defined as a reduction in the size of that lobe by at least 50% \[[@CR8]\], or the presence of obvious ductal crowding on sectional imaging or cholangiography \[[@CR1]--[@CR3], [@CR8]--[@CR10]\] (Figs. [1](#Fig1){ref-type="fig"}, [2](#Fig2){ref-type="fig"}and [3](#Fig3){ref-type="fig"}). Fig. 1**a**--**e** A patient with right lobe atrophy associated with cholangiocarcinoma. **a**--**c** Contrast-enhanced CT; **d, e** T2-weighted magnetic resonance imaging (MRI)/magnetic resonance cholangiopancreatogram (MRCP). **a** The right lobe is atrophied, and lies posteriorly with markedly dilated ducts. **b** The caudate lobe is probably hypertrophied (*black arrow*), and there is definite hypertrophy of segment IV (*white arrow*) and the left lateral segments (*curved arrow*). **c** The hypertrophied left lobe (segment III) extends inferiorly (*white arrow*). **d, e** Within the atrophied lobe, the ducts are markedly dilated and crowded (*white arrow*). **e** The ducts of the hypertrophied lobe are mildly dilated and spread out (*arrowhead*)Fig. 2**a**--**c** A patient with right lobar atrophy and left lobar hypertrophy associated with cholangiocarcinoma. **a** The right lobe is atrophic with markedly dilated ducts (*arrow*) on computed tomography (CT). The left lobe, and probably the caudate lobe (*arrowhead*), are hypertrophied. A stent is in place (*curved arrow*). **b** The atrophied lobe (*arrow*) shows lower attenuation relative to the non-atrophied lobe on CT-IVC. **c** CT-IVC surface-rendered reformat. The ducts draining segments II and III in the hypertrophied lobe are spread out (*arrow*), relative to the ducts of the atrophied lobeFig. 3**a**--**c** A patient with left lobe atrophy and right lobe hypertrophy associated with cholangiocarcinoma. **a, b** CT demonstrates a "step" in the contour between the atrophied and non-atrophied lobes (*curved arrow*). The ducts within the atrophied left lobe appear crowded and markedly dilated (*arrowhead*). The caudate lobe is clearly hypertrophied (*arrow*). **c** The hypertrophied right lobe has a "bulbous" visceral contour inferiorly (*arrows*)

As the left lobe is normally smaller than the right, being 40-70% of the right lobe volume \[[@CR11]--[@CR15]\], it is important to factor this into assessment of size difference between the two lobes.

There is a reduction in the volume of hepatic parenchyma between the dilated bile ducts, so the actual parenchymal reduction is frequently greater than the overall lobar volume reduction. The dilated ducts consequently become more crowded and they appear to extend more peripherally towards the liver capsule, somewhat analogous to bronchial dilatation in bronchiectasis (Fig. [1](#Fig1){ref-type="fig"}).

With right lobe atrophy, the atrophic lobe tends to "rotate" more superiorly and posteriorly (Fig. [1](#Fig1){ref-type="fig"}). In left lobe atrophy, the lobe is smaller but otherwise not appreciably displaced (Fig. [3](#Fig3){ref-type="fig"}).

Contour "step" {#Sec4}
--------------

There is often a change in hepatic contour, or a "step", between the atrophied and non-atrophied parts (Figs. [3](#Fig3){ref-type="fig"} and [8](#Fig8){ref-type="fig"}). This "step" sign, when present, allows more confident diagnosis of atrophy and is a useful sign when determining the lobar or segmental distribution of atrophy. Fig. 4**a**--**c** A patient with atrophy of the left lobe and hypertrophy of the right lobe associated with cholangiocarcinoma. **a**--**c** Portal venous phase contrast-enhanced CT. **a**, **b** A small portion of the atrophied left lobe is visible (**a**); the visceral surface of the hypertrophied right lobe appears "bulbous" (*curved arrows*). **c** The increase in dimensions and inferior extent of the hypertrophied right lobe is more apparent in the coronal plane. The bulbous visceral surface of the hypertrophied right lobe is again demonstrated (*arrow*)

CT attenuation and MRI signal intensity {#Sec5}
---------------------------------------

Atrophied liver parenchyma relative to non-atrophied parenchyma may show lower attenuation on pre-contrast CT \[[@CR16]\], higher attenuation during the hepatic arterial phase of contrast-enhanced CT \[[@CR4], [@CR17]\], decreased signal intensity on T1-weighted MRI and increased signal intensity on T2-weighted MRI \[[@CR17], [@CR18]\].

Some of these features are illustrated in Fig. [5](#Fig5){ref-type="fig"}, where the atrophied parenchyma shows lower attenuation on pre-contrast CT, and lower signal intensity on T1-weighted MRI. Fig. 5**a**--**c** A patient with left lobe atrophy associated with malignant hilar biliary obstruction due to metastasis of colorectal origin. The left portal vein branch is occluded. **a** Non-contrast-enhanced CT. The atrophied lobe shows lower attenuation than the non-atrophied lobe. **b, c** T1-weighted MRI. The atrophied left lobe shows lower signal intensity than the hypertrophied right lobe

An explanation for these findings on pre-contrast CT and T1-weighted MRI could be the increased water content in that portion of liver resulting from oedema, arterio-portal shunting \[[@CR19]\] and/or fibrosis \[[@CR17]\] within the atrophied lobe/segment.

In our experience, these CT attenuation and MRI signal intensity changes are not present in the majority of patients with lobar or segmental liver atrophy.

The atrophic liver parenchyma may also show lower attenuation on CT intravenous cholangiography (CT-IVC) (Fig. [2](#Fig2){ref-type="fig"}). This finding is explained by the reduced hepatocyte function and/or number, and consequently decreased contrast medium uptake and excretion by the atrophic parenchyma.

Compensatory hypertrophy {#Sec6}
========================

Lobar volume increase and duct spreading {#Sec7}
----------------------------------------

In patients with lobar or segmental liver atrophy, the non-atrophied parenchyma may undergo compensatory hyperplasia (more often referred to as hypertrophy, even though histologically the volume increase results from hyperplasia) (Figs. [1](#Fig1){ref-type="fig"}, [2](#Fig2){ref-type="fig"}, [3](#Fig3){ref-type="fig"}, [4](#Fig4){ref-type="fig"}, [6](#Fig6){ref-type="fig"}, [7](#Fig7){ref-type="fig"}, [8](#Fig8){ref-type="fig"}) \[[@CR3], [@CR5]\]. Compensatory hypertrophy is common \[[@CR4], [@CR8]\] and is important to recognise as it helps with recognition of contralateral atrophy, and has critical importance in planning surgical resection or interventional approaches to biliary decompression \[[@CR3], [@CR7]\]. Fig. 6**a**--**d** A patient with right lobe and left lateral segmental atrophy associated with cholangiocarcinoma. **a** Diagram representing a variant segment IV duct draining into the common hepatic duct (*CHD*) (*RASD* right anterior sectoral duct, *RPSD* right posterior sectoral duct, *RHD* right hepatic duct, *LHD* left hepatic duct, *IV* segment four duct). **b** Endoscopic retrograde cholangiopancreatogram (ERCP) demonstrates the normal calibre segment IV duct (*arrow*) draining into the common hepatic duct, inferior to the hilar stricture. **c**, **d** CT demonstrates atrophy of the right lobe and left lateral segments, and hypertrophy of segment IVFig. 7**a**--**d** A patient with left lobe and right anterior segmental atrophy associated with cholangiocarcinoma. **a** Diagram representing a variant right anterior sectoral duct (RASD) draining into the left hepatic duct (LHD) (RPSD right posterior sectoral duct, CHD common hepatic duct). **b** Percutaneous transjejunal cholangiogram demonstrates a variant RASD (*straight arrow*) draining into the LHD (*arrowhead*). The RPSD (*curved arrow*) is seen. **c**, **d** CT demonstrates atrophy of the left lobe and right anterior segments, and hypertrophy of the right posterior segments. Note the convex ("bulbous") visceral surface of the hypertrophied right posterior segments inferiorly (*curved arrows*)Fig. 8**a**--**d** A patient with segmental atrophy associated with cholangiocarcinoma; the right posterior sectoral duct drained into the left hepatic duct. **a** Diagram representing a variant right posterior sectoral duct (*RPSD*) draining into the left hepatic duct (*LHD*) (*RASD* right anterior sectoral duct, *CHD* common hepatic duct). **b** CT demonstrates atrophy of the left lobe (*black arrow*) and right posterior segments (*white arrow*), and hypertrophy of the right anterior segments. **c** Note the "step" in the contour between the left lobe/right anterior segments (*arrow*), and between the right anterior segments/ right posterior segments (*arrowhead*). **d** Note the "bulbous" contour of the visceral surface of the hypertrophied right anterior segments inferiorly (*arrow*)

Contrary to the crowded appearance of bile ducts in an atrophic lobe, those in a hypertrophied lobe appear relatively spread out (Figs. [1](#Fig1){ref-type="fig"}, [2](#Fig2){ref-type="fig"}). This spreading is most obvious when it affects the left lateral segments with resulting increased separation of the segment II and III ducts (Fig. [2](#Fig2){ref-type="fig"}c).

The relative occurrence of compensatory hypertrophy in patients with right versus left lobe atrophy has received little attention in the English literature. In two small series, one reported an equal rate of compensatory hypertrophy \[[@CR8]\], whereas the other showed a higher rate in patients with right lobe atrophy \[[@CR20]\].

In our experience compensatory hypertrophy is more common in patients with right lobe atrophy than left lobe atrophy, possibly because right lobe hypertrophy is more difficult to perceive.

In left lobe hypertrophy, the main increase in dimensions occurs in the axial plane on CT, which is the standard imaging plane (Figs. [1](#Fig1){ref-type="fig"}, [2](#Fig2){ref-type="fig"}). Normally, as mentioned above, the left liver lobe is substantially smaller than the right. Therefore, left lobe hypertrophy as a percentage change from baseline volume may be more substantial and therefore more obvious. Left lobe hypertrophy extends towards the left (Fig. [2a](#Fig2){ref-type="fig"}), and the left lateral segments tend to extend inferiorly into the central abdomen (Fig. [1](#Fig1){ref-type="fig"}c).

In cases of right lobe hypertrophy, the increase in dimensions is more obvious in the coronal plane (Fig. [4](#Fig4){ref-type="fig"}c). In the axial plane the hypertrophied right lobe (or segments) tends to show a prominent convex or "bulbous" contour of the visceral surface (Figs. [3](#Fig3){ref-type="fig"}, [4](#Fig4){ref-type="fig"}, [7](#Fig7){ref-type="fig"}, [8](#Fig8){ref-type="fig"}). To our knowledge, this finding has not previously been described. As the right lobe is normally larger than the left the degree of hypertrophy has to be more marked for it to be conspicuous. The recognition of the "bulbous" contour sign as well as the use of coronal CT or MRI should allow more ready recognition of right lobe hypertrophy.

Caudate lobe {#Sec8}
------------

In the presence of right or left lobe atrophy the caudate lobe may be atrophied or hypertrophied or neither (Figs. [1](#Fig1){ref-type="fig"}, [2](#Fig2){ref-type="fig"}, [3](#Fig3){ref-type="fig"}). In our experience the latter is the most common.

The development of atrophy or hypertrophy is likely to be determined by the involvement of caudate bile duct obstruction, which is variable in hilar malignant obstruction, as well as the status of the left portal vein, which provides the dominant portal supply to the caudate lobe \[[@CR20], [@CR21]\].

Segmental atrophy/hypertrophy associated with hilar biliary anatomical variation {#Sec9}
================================================================================

Unilateral biliary obstruction tends to result in a pattern of lobar atrophy with contralateral lobar hypertrophy \[[@CR6]\]. In at least some cases of lobar atrophy associated with cholangiocarcinoma, the tumour arises more peripherally, at which stage it is often asymptomatic, before it extends to the confluence of the right and left ducts causing jaundice \[[@CR3]--[@CR5]\]. During this time the atrophy and hypertrophy processes are occurring \[[@CR6]\]. With standard hilar biliary anatomy this process results in lobar atrophy with or without compensatory hypertrophy of the contralateral lobe \[[@CR3], [@CR4], [@CR6]\]. Variations in hilar biliary anatomy, however, have the potential to change the results of this progression so that the distribution of atrophy and hypertrophy may be more complex (Figs. [6](#Fig6){ref-type="fig"}, [7](#Fig7){ref-type="fig"}, [8](#Fig8){ref-type="fig"}). Such variations are common \[[@CR22], [@CR23]\]. Two of the most common variations are drainage of either the right posterior or right anterior sectoral ducts to the left hepatic duct (Figs. [7](#Fig7){ref-type="fig"}, [8](#Fig8){ref-type="fig"}). To our knowledge, there has been only one case report describing the complex pattern of atrophy and hypertrophy resulting from such anatomical variations in patients with cholangiocarcinoma \[[@CR24]\].

Recognition of atypical patterns of atrophy and hypertrophy arising from hilar biliary anatomical variations is important as it has major implications for selection of the most appropriate duct for palliative decompressive stenting, whether it is via an endoscopic or percutaneous approach. Stenting an atrophic lobe can increase the risk of cholangitis developing subsequently \[[@CR7]\], is unlikely to relieve jaundice and does not reverse the process of atrophy \[[@CR3]\].

Three patterns of segmental atrophy/hypertrophy associated with hilar biliary anatomical variations are illustrated in Figs. [6](#Fig6){ref-type="fig"}, [7](#Fig7){ref-type="fig"}, [8](#Fig8){ref-type="fig"}, all in patients with cholangiocarcinoma.

Conclusion {#Sec10}
==========

Recognising the presence of lobar or segmental atrophy in patients with biliary obstruction is important because of the implications for treatment. The imaging signs are a combination of morphological changes resulting from volume loss and increase respectively in atrophy and hypertrophy, as well as attenuation changes on CT and CT-IVC, and signal changes on MRI. Hilar biliary anatomical variants result in a range of unusual but predictable patterns of segmental atrophy with or without hypertrophy.
